Complement Activation in Systemic Lupus Erythematosus Patients with Low Disease Activity Is Not Inhibited by Hydroxychloroquine

被引：0
作者：
Troldborg, Anne Margrethe [1 ]
Hansen, Annette [2 ]
Stengaard-Pedersen, Kristian [2 ]
Thiel, Steffen [2 ]
机构：
[1] Aarhus Univ Hosp, Aarhus, Denmark
[2] Aarhus Univ, Aarhus, Denmark
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1810
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Complement factor B as a clinical marker of disease activity in patients with systemic lupus erythematosus.
    Watanabe, H
    Sato, Y
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S576 - S576
  • [22] Hydroxychloroquine and pregnancy on lupus flares in Korean patients with systemic lupus erythematosus
    Koh, J. H.
    Ko, H. S.
    Kwok, S-K
    Ju, J. H.
    Park, S-H
    LUPUS, 2015, 24 (02) : 210 - 217
  • [23] Patients' perception of systemic lupus erythematosus disease activity
    Sushchuk, EA
    Torgashina, AV
    RHEUMATOLOGY, 2005, 44 : I137 - I137
  • [24] Additional Hydroxychloroquine Therapy Regulates Adipokines in Systemic Lupus Erythematosus with Stable Disease Activity
    Wakiya, Risa
    Ueeda, Kiyo
    Shimada, Hiromi
    Nakashima, Shusaku
    Kato, Mikiya
    Miyagi, Taichi
    Mai, Mansour
    Sugihara, Koichi
    Semba, Rina
    Mizusaki, Mao
    Kameda, Tomohiro
    Dobashi, Hiroaki
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3684 - 3686
  • [25] Hydroxychloroquine in systemic lupus erythematosus (SLE)
    Ponticelli, C.
    Moroni, G.
    EXPERT OPINION ON DRUG SAFETY, 2017, 16 (03) : 411 - 419
  • [26] HYDROXYCHLOROQUINE IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    DISLA, E
    BRAR, H
    TARANTA, A
    NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (14) : 1046 - 1046
  • [27] Ficolin-3 mediated complement activation in patients with systemic lupus erythematosus
    Hein, E.
    Nielsen, C. T.
    Munthe-Fog, L.
    Jacobsen, S.
    Garred, P.
    MOLECULAR IMMUNOLOGY, 2013, 56 (03) : 276 - 276
  • [28] Association of the Spectrum of Cutaneous Lupus Erythematosus with Disease Activity and Systemic Manifestations in Patients with Systemic Lupus Erythematosus
    Brahmanti, Herwinda
    Wahono, Cesarius Singgih
    Pratama, Mirza Zaka
    Rahman, Perdana Aditya
    Suhendra, Riski Bagus
    Rizky, Amalia Novia
    Mukti, Nabilah Hanifah
    MEDITERRANEAN JOURNAL OF RHEUMATOLOGY, 2024, 35 (01): : 143 - 149
  • [29] SERUM COMPLEMENT FACTOR I IS ASSOCIATED WITH DISEASE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS
    Tseng, Min-Hua
    Lin, Shih-Hua
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [30] Low Disease Activity Early in the Course of Systemic Lupus Erythematosus
    Ugarte-Gil, Manuel F.
    Alarcon, Graciela S.
    JOURNAL OF RHEUMATOLOGY, 2024, 51 (08) : 739 - 740
12345